STAR

Strides Pharma Science Share Price

 

 

Start SIP in STAR

Start SIP

Performance

  • Low
  • ₹908
  • High
  • ₹938
  • 52 Week Low
  • ₹513
  • 52 Week High
  • ₹1,025
  • Open Price₹934
  • Previous Close₹938
  • Volume223,929

Investment Returns

  • Over 1 Month + 2.86%
  • Over 3 Month + 8.54%
  • Over 6 Month + 2.46%
  • Over 1 Year + 32.42%

Smart Investing Starts Here Start SIP with Strides Pharma Science for Steady Growth!

Invest Now

Strides Pharma Science Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 21.1
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 8,397
  • P/B Ratio
  • 3
  • Average True Range
  • 32.33
  • EPS
  • 47.3
  • Dividend Yield
  • 0.4
  • MACD Signal
  • 3.92
  • RSI
  • 51.31
  • MFI
  • 73.74

Strides Pharma Science Financials

Strides Pharma Science Technicals

EMA & SMA

Current Price
₹911.05
-27.25 (-2.9%)
pointer
  • Bearish Moving Average 4
  • Bullish Moving Average 12
  • 20 Day
  • ₹908.62
  • 50 Day
  • ₹895.69
  • 100 Day
  • ₹877.45
  • 200 Day
  • ₹864.00

Resistance and Support

919.12 Pivot Speed
  • R3 960.53
  • R2 949.42
  • R1 930.23
  • S1 899.93
  • S2 888.82
  • S3 869.63

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Strides Pharma Science Ltd. is a global pharmaceutical company engaged in the development, manufacturing, and marketing of generic drugs. It focuses on niche therapeutic segments, including anti-retrovirals, oncology, and central nervous system, serving markets worldwide.

Strides Pharma Science has an operating revenue of Rs. 4,684.63 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 11% is healthy, ROE of 140% is exceptional. The company has a reasonable debt to equity of 22%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 15% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 54 which is a POOR score indicating inconsistency in earnings, a RS Rating of 84 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Strides Pharma Science Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-10-31 Quarterly Results
2025-07-29 Quarterly Results
2025-05-22 Audited Results & Final Dividend
2025-01-30 Quarterly Results
2024-10-24 Quarterly Results
Date Purpose Remarks
2025-07-22 FINAL Rs.4.00 per share(40%)Final Dividend
2024-09-09 FINAL Rs.2.50 per share(25%)Final Dividend
2023-08-04 FINAL Rs.1.50 per share(15%)Final Dividend
2021-08-06 FINAL Rs.2.50 per share(25%)Final Dividend
View Strides Pharma Science Dividend History Arrow

Strides Pharma Science F&O

Strides Pharma Science Shareholding Pattern

27.86%
8.48%
2.94%
28.51%
0.01%
22.43%
9.77%

About Strides Pharma Science

  • NSE Symbol
  • STAR
  • BSE Symbol
  • 532531
  • Managing Director & Group CEO
  • Mr. Badree Komandur
  • ISIN
  • INE939A01011

Similar Stocks to Strides Pharma Science

Strides Pharma Science FAQs

Strides Pharma Science share price is ₹911 As on 27 December, 2025 | 02:36

The Market Cap of Strides Pharma Science is ₹8397.4 Cr As on 27 December, 2025 | 02:36

The P/E ratio of Strides Pharma Science is 21.1 As on 27 December, 2025 | 02:36

The PB ratio of Strides Pharma Science is 3 As on 27 December, 2025 | 02:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23